Problems grow for neuromodulation firm Helius Medical Technologies

By SharpBrains | February 15, 2019

Investor Alert: Kaplan Fox Inves­ti­gates Helius Med­ical Tech­nolo­gies, Inc. (press release): “NEW YORK, Feb. 7, 2019 /PRNewswire/ — Kaplan Fox & Kil­sheimer LLP has been inves­ti­gat­ing claims on behalf of investors of Helius Med­ical Tech­nologiues, Inc. (“Helius” or the “Com­pa­ny”) (Nas­daq: HSDT). On Jan­u­ary 22, 2019, after the mar­ket opened, White Dia­mond Research published

Read More